| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Streeterville Capital LLC
|
390.930k | 8.04% | +352.359k | Jul 06 2026 |
| 2 |
Mailman (Josh)
|
16.781k | 0.35% | +16.722k | Dec 17 2025 |
| 3 |
Iliad Research & Trading, L.P.
|
12.571k | 0.26% | +11.662k | Dec 11 2025 |
| 4 |
UBS Financial Services, Inc.
|
4.000k | 0.08% | +774.000 | Jun 30 2026 |
| 5 |
Tower Research Capital LLC
|
1.160k | 0.02% | +1.094k | Jun 30 2026 |
|
1
Streeterville Capital LLC
|
8.04%
390.930k
|
|
2
Mailman (Josh)
|
0.35%
16.781k
|
|
3
Iliad Research & Trading, L.P.
|
0.26%
12.571k
|
|
4
UBS Financial Services, Inc.
|
0.08%
4.000k
|
|
5
Tower Research Capital LLC
|
0.02%
1.160k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 8.75% of Jaguar Health, Inc., with Streeterville Capital LLC the biggest at 8.04%, followed by Mailman (Josh) (0.35%) and Iliad Research & Trading, L.P. (0.26%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Jaguar Health, Inc. has risen over the past 12 months from around 2.2% to 4.3% of the float. More and more market participants are betting on falling prices. That reflects growing skepticism, but also carries upside potential through a possible short squeeze. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


